Quiet on the insider front: nobody at DNA X, Inc. bought or sold SONM shares with their own money this past year.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters. Big money check: 9 institutions held SONM as of Q2 2026, and more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | LYTTON LAURENCE W | 10% Owner | Sell | 400,514 | $1.39 | $557K | SEC |
| Jun 30, 2025 | LYTTON LAURENCE W | 10% Owner | Sell | 466,402 | $1.50 | $700K | SEC |
| Apr 25, 2025 | Cassano James S | Director | Sell | 23,381 | $1.45 | $34K | SEC |
| Apr 25, 2025 | MULICA MICHAEL C | Director | Sell | 27,818 | $1.45 | $40K | SEC |
| Apr 25, 2025 | Steenstra Jack | Director | Sell | 23,381 | $1.45 | $34K | SEC |
| Apr 25, 2025 | Becher Charles | Officer | Sell | 31,326 | $1.45 | $45K | SEC |
| Apr 25, 2025 | Wang Jeffrey | Director | Sell | 4,478 | $1.45 | $6K | SEC |
| Apr 25, 2025 | Crolius Clayton | CFO | Sell | 11,634 | $1.45 | $17K | SEC |
| Nov 14, 2024 | MULICA MICHAEL C | Director | Sell | 2,559 | $3.28 | $8K | SEC |
| Jul 23, 2024 | Steenstra Jack | Director | Sell | 1,623 | $3.67 | $6K | SEC |
| Jul 23, 2024 | Cassano James S | Director | Sell | 1,623 | $3.68 | $6K | SEC |
| Jul 23, 2024 | Wang Jeffrey | Director | Sell | 1,623 | $3.67 | $6K | SEC |
| Jun 24, 2024 | MULICA MICHAEL C | Director | Sell | 36,016 | $0.69 | $25K | SEC |
| Jun 24, 2024 | Cassano James S | Director | Sell | 36,015 | $0.69 | $25K | SEC |
| Jun 24, 2024 | Steenstra Jack | Director | Sell | 35,882 | $0.69 | $25K | SEC |
There were no open-market insider trades in SONM in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
9 investment managers reported holding SONM in SEC Form 13F filings for Q2 2026.
No congressional trades in SONM were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).